Arrowhead Pharma (ARWR) PT Raised to $123 at B.Riley
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $71.86 +4.46%
Rating Summary:
18 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 8
Rating Summary:
18 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 8
Join SI Premium – FREE
B.Riley analyst Chad L. Mabry raised the price target on Arrowhead Pharma (NASDAQ: ARWR) to $123.00 (from $101.00) while maintaining a Buy rating.
You May Also Be Interested In
- Jefferies Upgrades Valeo SA (FR:FP) (VLEEY) to Buy
- Soitec (SOI:FP) (SLOIF) PT Raised to EUR200 at Kepler Cheuvreux
- Air Liquid SA (AI:FP) (AIQUY) PT Raised to EUR192 at Deutsche Bank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
